Engaged in technical administration of clinical biochemical testing. Authorized signatory for biochemistry under CNAS accreditation. Specialized in applied analysis and quality control of biochemical assays.

Focus on novel biochemical detection technologies and new tumor biomarkers for clinical auxiliary diagnosis and prognosis research.

1. Establishment  and Validation of Prognostic Nomograms Based on Serum Copper Level for Patients With Early-Stage Triple-Negative Breast Cancer. Front Cell Dev Biol. 2021 Nov 25;9:770115.

2. Expression of CD4+CD25+CD127Low regulatory T cells and cytokines in peripheral blood of patients with primary liver carcinoma. Int J Med Sci. 2020 Feb 24;17(6):712-719. 

3. Target-induced proximity ligation triggers recombinase polymerase amplification and transcription-mediated amplification to detect tumor-derived exosomes in nasopharyngeal carcinoma with high sensitivity. Biosensors and Bioelectronics. 2018 Apr 15;102:204-210

4. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics. Int J Biol Sci. 2018 Apr 5;14(5):549-556; 

5. A Novel Inflammation-Based Stage (I Stage) predicts overall survival of patients with nasopharyngeal carcinoma. Int. J. Mol. Sci. 201611;1422-0067